Clinical attrition due to biased preclinical assessments of potential efficacy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pharmacology and Therapeutics

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PHARMTHERA.2007.05.002PMID 17574680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Value of Improving the Productivity of the Drug Development Process

  2012cited by this paper
• The effect of experimenter bias on the performance of the albino rat.

  2007cited by this paper
• Meehl's contribution to clinical versus statistical prediction.

  2006cited by this paper
• Why drugs fail--a study on side effects in new chemical entities.

  2005cited by this paper
• Target-based drug discovery: is something wrong?

  2005cited by this paper
• Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II

  2005cited by this paper
• Nicotine abstinence produces content-specific stroop interference

  2005cited by this paper
• Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I

  2005cited by this paper
• Group performance and decision making.

  2004cited by this paper
• The cost of new drug discovery and development.

  2004cited by this paper
• Spontaneous Skepticism: The Interplay of Motivation and Expectation in Responses to Favorable and Unfavorable Medical Diagnoses

  2003cited by this paper
• Biased predecision processing.

  2003cited by this paper
• Pharmaceutical industry sponsorship and research outcome and quality: systematic review

  2003cited by this paper
• Hindsight ≠ foresight: the effect of outcome knowledge on judgment under uncertainty*

  2003cited by this paper
• The price of innovation: new estimates of drug development costs.

  2003cited by this paper
• A path to improved pharmaceutical productivity

  2003cited by this paper
• Heuristics and Biases: Clinical versus Actuarial Judgment

  2002cited by this paper
• Citation bias of hepato-biliary randomized clinical trials.

  2002cited by this paper
• Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems

  2002cited by this paper
• Confirmation bias in sequential information search after preliminary decisions: an expansion of dissonance theoretical research on selective exposure to information.

  2001cited by this paper
• Too many targets, not enough target validation.

  2001cited by this paper
• Risks in new drug development: Approval success rates for investigational drugs

  2001influential reference
• Systematic reviews in health care: Assessing the quality of controlled clinical trials.

  2001cited by this paper
• Quality of decision making and group norms.

  2001cited by this paper
• Transcutaneous electrical nerve stimulation (TENS) for chronic pain.

  2000cited by this paper
• Determinants and effects of attentional bias in smokers.

  2000cited by this paper
• Clinical versus mechanical prediction: a meta-analysis.

  2000cited by this paper
• The potential for social contextual and group biases in team decision-making: biases, conditions and psychological mechanisms

  2000cited by this paper
• Subgroup analysis and other (mis)uses of baseline data in clinical trials.

  2000cited by this paper
• The uncertainty principle and industry-sponsored research.

  2000cited by this paper
• A randomized controlled study of reviewer bias against an unconventional therapy

  2000cited by this paper
• How Scientists Explain Disease

  1999cited by this paper
• The Milgram Paradigm After 35 Years: Some Things We Now Know About Obedience to Authority1

  1999cited by this paper
• Book Review The Powerful Placebo: From ancient priest to modern physician By Arthur K. Shapiro and Elaine Shapiro. 280 pp. Baltimore, Johns Hopkins University Press, 1997. $39.95. 0-8018-5569-1

  1998cited by this paper
• The Golf-Ball Illusion: Evidence for Top-down Processing in Weight Perception

  1998cited by this paper
• Top-down influences on stereoscopic depth-perception

  1998cited by this paper
• Bias in reporting clinical trials.

  1998cited by this paper
• 175th anniversary lecture. Medical journals and the shaping of medical knowledge.

  1998cited by this paper
• Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine

  1998cited by this paper
• Biases in the interpretation and use of research results.

  1998influential reference
• Managing the drug discovery/development interface

  1997cited by this paper
• The Reiteration Effect in Hindsight Bias

  1997cited by this paper
• Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation.

  1997cited by this paper
• Why are drug development programs growing in size and cost? A view from industry.

  1997cited by this paper
• Why are drug development programs growing in size and cost? A view from industry.

  1997cited by this paper
• Bias in judgment: Comparing individuals and groups.

  1996cited by this paper
• A disconfirmation bias in the evaluation of arguments.

  1996cited by this paper
• Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience.

  1996cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Subverting randomization in controlled trials.

  1995cited by this paper
• Quotation bias in reviews of the diet-heart idea.

  1995cited by this paper
• Reviewer bias: a blinded experimental study.

  1994cited by this paper
• The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial

  1994cited by this paper
• Novum organum : with other parts of The great instauration

  1994cited by this paper
• Mental contamination and mental correction: unwanted influences on judgments and evaluations.

  1994cited by this paper
• Overlooking ethics in the search for objectivity and misconduct in science

  1993cited by this paper
• The power of nonspecific effects in healing: Implications for psychosocial and biological treatments

  1993cited by this paper
• Escalating Commitment in Individual and Group Decision Making: A Prospect Theory Approach

  1993cited by this paper
• The Influence of Prior Beliefs on Scientific Judgments of Evidence Quality

  1993cited by this paper
• Scientists' Evaluations of Research: the Biasing Effects of the Importance of the Topic

  1993cited by this paper
• How Sound Is the Double-Blind Design for Evaluating Psychotropic Drugs?

  1993cited by this paper
• Debias the environment instead of the judge: an alternative approach to reducing error in diagnostic (and other) judgment.

  1993cited by this paper
• The Effects of Graduate

  1993cited by this paper
• Publication Bias: The Problem That Won't Go Away

  1993cited by this paper
• Reviewer bias against replication research.

  1993cited by this paper
• Seeing is Believing: The Role of ‘Preconscious' Perceptual Processing in Delusional Misidentification

  1992cited by this paper
• A meta-analysis of antidepressant outcome under "blinder" conditions.

  1992cited by this paper
• How We Know What Isn't So: The Fallibility of Human Reason in Everyday Life

  1991cited by this paper
• Publication bias in clinical research.

  1991influential reference
• Detecting fabrication of data in a multicenter collaborative animal study.

  1991cited by this paper
• Suspended judgment. Is the scientific paper a fraud?

  1991cited by this paper
• Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

  1991cited by this paper
• Replication in behavioral research.

  1990cited by this paper
• A longitudinal study of the effects of undergraduate training on reasoning.

  1990cited by this paper
• The Threat and the Glory: Reflections on Science and Scientists

  1990cited by this paper
• Editorial bias against replication research.

  1990cited by this paper
• Replications, strict replications, and conceptual replications: Are they important?

  1990cited by this paper
• Publishing by--and for?--the numbers.

  1990cited by this paper
• The case for motivated reasoning.

  1990cited by this paper
• Rules of evidence and clinical recommendations on the use of antithrombotic agents.

  1989influential reference
• Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

  1989cited by this paper
• Physics of the Photographic Latent Image

  1989cited by this paper
• Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials.

  1989cited by this paper
• Publication bias and dissemination of clinical research.

  1989cited by this paper
• Choosing covariates in the analysis of clinical trials.

  1989cited by this paper
• Changing Order: Replication and Induction in Scientific Practice by H. M. Collins (review)

  1988cited by this paper
• Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

  1988cited by this paper
• Pediatric malingering: the capacity of children to fake believable deficits on neuropsychological testing.

  1988cited by this paper
• The Effects of Graduate Training on Reasoning: Formal Discipline and Thinking About Everyday-Life Events

  1988cited by this paper
• Misrepresentation and responsibility in medical research.

  1987cited by this paper
• Teaching reasoning.

  1987cited by this paper
• Reference bias in reports of drug trials.

  1987cited by this paper
• Lessons from overviews of cardiovascular trials.

  1987cited by this paper
• Analyzing Multivariate Data

  1987cited by this paper
• Toward an integration of cognitive and motivational perspectives on social inference: A biased hypothesis-testing model

  1987cited by this paper
• Fraud in science.

  1987cited by this paper
• Confronting publication bias: a cohort design for meta-analysis.

  1987cited by this paper
• Publication bias and clinical trials.

  1987cited by this paper
• Statistical problems in the reporting of clinical trials. A survey of three medical journals.

  1987cited by this paper
• Effect of positive findings on submission and acceptance rates: A note on meta-analysis bias.

  1986cited by this paper

• Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects

  2022cites this paper
• Zebrafish as a Mainstream Model for In Vivo Systems Pharmacology and Toxicology.

  2022cites this paper
• Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials

  2021cites this paper
• Recent advances in human respiratory epithelium models for drug discovery.

  2021cites this paper
• Reality and Legality: Disentangling What Is Actual from What Is Tolerated in Comparisons of Hemp Extracts with Pure CBD

  2020cites this paper
• Using the concept of “deserved trust” to strengthen the value and integrity of biomedical research

  2020cites this paper
• Improving the odds of drug development success through human genomics: modelling study

  2019cites this paper
• Non-reproducible Research

  2018cites this paper
• Biomaterials‐Based Approaches to Tumor Spheroid and Organoid Modeling

  2018cites this paper
• The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials

  2018cites this paper
• Scientific productivity: An exploratory study of metrics and incentives

  2018cites this paper
• Translational Modeling and Simulation for Molecularly Targeted Small Molecule Anticancer Agents: Case Studies of Multiple Tyrosine Kinase Inhibitors, Crizotinib and Lorlatinib

  2018cites this paper
• Flipping the odds of drug development success through human genomics

  2017cites this paper
• Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery

  2017cites this paper
• Experimental Design for Laboratory Biologists: Maximising Information and Improving Reproducibility. By Stanley E. Lazic. Cambridge and New York: Cambridge University Press. $175.00 (hardcover); $64.99 (paper). xv + 412 p.; ill.; index. ISBN: 978-1-107-07429-3 (hc); 978-1-107-42488-3 (pb); 978-1-316

  2017cites this paper
• Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015).

  2016cites this paper
• Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside

  2016cites this paper
• Examining the Predictive Validity of NIH Peer Review Scores

  2015cites this paper
• Correction: Examining the Predictive Validity of NIH Peer Review Scores

  2015cites this paper
• NIH Peer Review

  2015cites this paper
• The Future of Preclinical Animal Models in Pharmaceutical Discovery and Development

  2015cites this paper
• Is animal research sufficiently evidence based to be a cornerstone of biomedical research?

  2014cites this paper
• Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

  2014cites this paper
• Reducing attrition in drug development: smart loading preclinical safety assessment.

  2014cites this paper
• Four disruptive strategies for removing drug discovery bottlenecks.

  2013cites this paper
• Qualification of cardiac troponins for nonclinical use: a regulatory perspective.

  2013cites this paper
• Animal models of chemically induced intestinal inflammation: predictivity and ethical issues.

  2013cites this paper
• Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework

  2013cites this paper
• Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?

  2013cites this paper
• Gait Analysis in Rats with Single Joint Inflammation: Influence of Experimental Factors

  2012cites this paper
• Review of the History and Current Status of Cell-Transplant Approaches for the Management of Neuropathic Pain

  2012cites this paper
• Translational Pharmacokinetic-Pharmacodynamic Modeling from Nonclinical to Clinical Development: A Case Study of Anticancer Drug, Crizotinib

  2012cites this paper
• Overview of Mouse Models for Psychiatric and Neurologic Disorders

  2012cites this paper
• Translational semantics and infrastructure: another search for the emperor's new clothes?

  2012cites this paper
• Qualitative pharmacology in a quantitative world: diminishing value in the drug discovery process.

  2011cites this paper
• Prospects for neurodegenerative and psychiatric disorder drug discovery

  2011cites this paper
• Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report

  2011cites this paper
• Early patient_Layout 1

  2011cites this paper
• The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies.

  2011cites this paper
• Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.

  2011cites this paper
• Predictive validity of behavioural animal models for chronic pain

  2011cites this paper
• Between Confidentiality and Scientific Exchange: The Place of Publication in Drug Discovery and Pharmaceutical Research

  2011cites this paper
• Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans

  2011cites this paper
• The potential for bias in reporting of industry‐sponsored clinical trials

  2011cites this paper
• Do technical and commercial biases contribute to the pharmaceutical industry's productivity problems? An analysis of how reordering priorities can improve productivity.

  2010cites this paper
• P450 biochips : development of a protein microarray platform for investigating cytochrome P450 clinical drug metabolism

  2010cites this paper
• An investigation into how radiographer’s comments influence doctor’s decisions in a busy Dublin A&E department

  2010cites this paper
• Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations

  2009cites this paper
• Substructure Mining of GPCR Ligands Reveals Activity-Class Specific Functional Groups in an Unbiased Manner

  2009cites this paper
• Clinical feasibility for cell therapy using human neuronal cell line to treat neuropathic behavioral hypersensitivity following spinal cord injury in rats.

  2009cites this paper
• Failure is an option: learning from unsuccessful proof-of-concept trials.

  2008cites this paper
• Development, Optimization and Use of Preclinical Behavioral Models to Maximize the Productivity of Drug Discovery for Alzheimer's Disease

  2008cites this paper
• PREFACE: What Do You Mean by “Translational Research”? An Enquiry Through Animal and Translational Models for CNS Drug Discovery: Reward Deficit Disorders

  2008cites this paper